This inventor holds 1 USPTO granted patent. Top assignee: Kymab Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yen-Ju Chen: Innovator in PCSK9 Antagonists
Introduction
Yen-Ju Chen is a prominent inventor based in Xinyi District, Taipei, Taiwan. She has made significant contributions to the field of biomedicine, particularly in the development of PCSK9 antagonists. Her innovative work has the potential to impact the treatment of various cardiovascular diseases.
Latest Patents
Yen-Ju Chen holds a patent related to Proprotein Convertase Subtilisin Kexin type 9 (PCSK9) antagonists. This invention encompasses antibodies and fragments, along with methods, uses, and combinations that could revolutionize therapeutic approaches in managing cholesterol levels.
Career Highlights
Currently, Yen-Ju Chen is associated with Kymab Limited, where she continues to advance her research and development efforts. Her expertise in the field has positioned her as a key player in the biopharmaceutical industry.
Collaborations
Yen-Ju Chen has collaborated with notable professionals such as Allan Bradley and Qi Liang. These partnerships have fostered a dynamic environment for innovation and discovery in her research endeavors.
Conclusion
Yen-Ju Chen's contributions to the field of PCSK9 antagonists exemplify her dedication to advancing medical science. Her work not only highlights her innovative spirit but also underscores the importance of collaboration in achieving groundbreaking results.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile